03.11.2025, 09:31

Russian biotech firm R-Pharm to build $200 mln drug plant in Kazakhstan

ASTANA. Nov 3 (Interfax-Kazakhstan) – The international biotech company R-Pharm, in partnership with Khan Tengri Biopharma, will build a pharmaceutical plant in Kazakhstan's new city of Alatau, the press service of the republic's prime minister reported.

To read the full news articles, Subscribe.

09:08PM
CIS Security Council secretaries to discuss security challenges and threats in CIS area

08:16PM
Almaty Airport to serve almost 5 times more passengers by 2050

08:02PM
Russia, Kazakhstan resume construction of fiber-optic line across Caspian Sea bed

05:00PM
Kazakhstan ships nearly 900,000 tonnes of 2025 grain harvest to China by rail

04:45PM
Russia set to develop nuclear energy cooperation with China - Rosatom

03:59PM
AVERAGE WEIGHTED RATE ON NOV 3, 2025 IS 528.31 TENGE FOR $1

03:16PM
Almaty court jails emergency officials over equipment failure during 2024 earthquake

03:04PM
Kazakhstan’s flaxseed exports surge 3.8-fold to 63,000 tonnes in September – Grain Union

02:44PM
Interfax-Kazakhstan issues its 1085th Oil&Gas Report

02:36PM
Kazatomprom boosted uranium output 12% in Jan-Sept

01:41PM
Annual inflation in Kazakhstan slowed to 12.6% in Oct